<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045068"><TermName>R101933</TermName><TermDefinition><DefinitionText>A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It belongs to the family of drugs called multidrug resistance inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>R101933</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad de hacer que las c√©lulas cancerosas respondan a los medicamentos a los que se han vuelto resistentes. Pertenece al tipo de medicamentos llamados inhibidores de la multirresistencia.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
